BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251013T140000
DTEND;TZID=Europe/London:20251013T150000
DTSTAMP:20260828T235951
CREATED:20250929T163601Z
LAST-MODIFIED:20251003T080807Z
UID:100115844-1760364000-1760367600@www.pathologynews.com
SUMMARY:TIA Centre Seminar Series - Towards Multimodal AI for Personalized Cancer Treatment
DESCRIPTION:The Tissue Image Analytics (TIA) Centre hosts a seminar series for those interested in computational pathology. The series invites researchers and leaders in computational pathology and related fields to present their work and foster thought-provoking discussions. \nThe next seminar will take place on Monday\, 13 October\, from 2–3 p.m. UK time. The Centre is delighted to announce that the session will feature Dr. Nadieh Khalili from Radboud UMC\, The Netherlands\, who will be joining online. \nAbstract\nThe integration of diverse data types—such as histopathology\, radiology\, and omics—offers a powerful opportunity to develop AI models that improve cancer diagnosis and treatment selection. In this talk\, I will present recent efforts from our group in developing and validating multimodal deep learning frameworks that predict treatment-relevant biomarkers directly from routine diagnostic images. I will highlight case studies in bladder and prostate cancer and discuss challenges related to data harmonization\, model generalization\, and clinical translation. \nRegister NowBio\nDr Nadieh Khalili is an Assistant Professor in AI at Radboud UMC\, where she leads research at the intersection of deep learning\, digital pathology\, and multi-modal data integration. Her work focuses on developing clinically meaningful AI tools for cancer diagnosis and treatment response prediction. She has a background in biomedical engineering and previously worked in R&D roles in industry. Dr Khalili is also actively involved in organizing scientific events and is a board member of the European Society of Digital Pathology.
URL:https://www.pathologynews.com/event/tia-centre-seminar-series-towards-multimodal-ai-for-personalized-cancer-treatment/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/png:https://www.pathologynews.com/wp-content/uploads/2025/09/TIA-Centre-Seminar-Series-Towards-Multimodal-AI-for-Personalized-Cancer-Treatment-.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250929T140000
DTEND;TZID=Europe/London:20250929T150000
DTSTAMP:20260828T235951
CREATED:20250827T141747Z
LAST-MODIFIED:20250829T120221Z
UID:100115260-1759154400-1759158000@www.pathologynews.com
SUMMARY:Evaluation of HER2-Low and Ultralow Status of Advanced Breast Carcinomas
DESCRIPTION:0000Days00Hrs00Min00SecJoin this webinar to discover how digital pathology with AI evaluation is a more sensitive method for HER2-low assessment. Dr. Anikó Kovács (Department of Clinical Pathology\, Sahlgrenska University Hospital\, Gothenburg\, Sweden) will present findings from a retrospective study on the HER2-low status of advanced breast carcinomas in core biopsies. \nThe aim of the study was to: \n\ncompare the outcome of HER2 scoring using conventional microscopy\, digital pathology\, and AI.\nassess changes in HER2-low status in core biopsies\, matching operation specimens\, and their distant metastases.\n\nRegister for the webinar to learn more about the findings and how AI can help determine a more accurate HER2-low status\, providing an exact percentage of each HER2 score within seconds with high accuracy. \nWho should join?\n\nPathologists involved in biomarker testing\nOncologists relying on HER2-low status in treatment decisions\nAnyone involved in breast cancer diagnostics or therapeutic decision-making\nAnyone interested in using or developing AI models for image analysis in digital pathology\n\nRegister NowSpeakersAnikó Kovács\, MD\, PhD\nAssociate Professor\, Pathologist\, and Lecturer\nSahlgrenska University Hospital \n\nHas worked in research in Sweden for the past 23 years\nBreast cancer research at the Leicester University in the UK\nResearch background also in Japan (Kitasato University) and Hungary\n\nRute Pedrosa\, PhD\nSenior Field Application Scientist\nAiforia Technologies \n\nHas worked at Aiforia for 2.5 years\nPhD at Erasmus University Rotterdam\, focusing on the pathogenesis of brain metastatic disease
URL:https://www.pathologynews.com/event/evaluation-of-her2-low-and-ultralow-status-of-advanced-breast-carcinomas/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/aiforia-her2-low-webinar-pathologynews.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250918T160000
DTEND;TZID=Europe/London:20250918T170000
DTSTAMP:20260828T235951
CREATED:20250827T150458Z
LAST-MODIFIED:20250827T152522Z
UID:100115270-1758211200-1758214800@www.pathologynews.com
SUMMARY:Intro to HALO®\, HALO AI\, and HALO Link 4.2
DESCRIPTION:0000Days00Hrs00Min00SecLearn about the exciting new features in the 4.2 versions of HALO\, HALO AI\, and HALO Link!\nSummaryIn this webinar\, Indica Labs will explore the new features and functionalities in HALO\, HALO AI\, and HALO Link 4.2 designed to enhance performance\, streamline workflows\, and expand analytical capabilities. In HALO 4.2\, new annotation tools such as a multi-select feature and improved annotation management\, including batch annotation import and rename\, boost efficiency. Also\, object data is moved out from the database into optimized parquet files\, significantly improving load times and overall system performance. \nHALO AI 4.2 offers channel-invariant pretrained models that streamline nuclear and cell segmentation by leveraging all fluorescent channels\, and multiple membrane markers can now be selected when further training the pretrained membrane segmentation model. Version 4.2 also brings an updated AI annotation tool that is smaller\, faster\, and optimized for pathology data\, delivering a smoother annotation experience. Users now have greater control over model training with adjustable hyperparameters\, including learning rates and class weights. \n\nIn version 4.2\, HALO Link now supports viewing Z-stacks on brightfield images. The latest version also introduces a Diagnostic Monitor add-on to help administrators troubleshoot performance issues with image loading. For those looking for additional ergonomics options\, integration with the 3D Connexion SpaceMouse is now available. Finally\, both HALO and HALO Link 4.2 support the use of third-party AI apps\, enabling models developed by users outside of HALO or by external vendors to be launched and viewed within the platforms. \n\nLearning Objectives\nLearn about third party AI Analysis support through API \nLearn about new annotation tools and object data storage in HALO \nLearn about streamlined nuclear and membrane segmentation using channel invariant pretrained models  \nLearn about using the 3D Connexion SpaceMouse for more ergonomic slide navigation in HALO Link \n\nRegister NowPresenterDr. Noemi Kedei\nDirector of Product\, Life Sciences\nIndica Labs  \nNoemi Kedei earned an MD degree from University Medical School of Debrecen\, Hungary. She did her postdoctoral training and worked later as a staff scientist in the Laboratory of Cancer Biology and Genetics\, NCI. Her research focused on identifying mechanisms involved in the differential effects of natural compounds and their engineered derivatives acting on protein kinase Cs (PKCs)\, validated targets for anti-cancer treatment. In 2018 she joined the Collaborative Protein Technology Resources (OSTR\, CCR\, NCI) core facility to implement a variety of spatial protein and transcriptomics technologies\, and lead related operations as services to NCI investigators. Noemi provided the expertise for development of project based customized antibody protein panels for detection of 40-60 protein targets at single cell level in tissue sections using the CODEX/Phenocycler fusion technology\, and ensured optimal and efficient instrument use. In addition\, she advised and supported users on tools for quantitative image analysis combining different AI-enabled HALO modules and NCI developed pipelines for downstream analysis. Noemi joined Indica Labs as Director of Product – Life Sciences in May\, 2025. 
URL:https://www.pathologynews.com/event/intro-to-halo-halo-ai-and-halo-link-4-2/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Intro-to-HALO®-HALO-AI-and-HALO-Link-4.2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250916T130000
DTEND;TZID=Europe/London:20250916T140000
DTSTAMP:20260828T235951
CREATED:20250827T133756Z
LAST-MODIFIED:20250827T152729Z
UID:100115251-1758027600-1758031200@www.pathologynews.com
SUMMARY:Can AI Predict Patient Outcomes in Ovarian Cancer?
DESCRIPTION:0000Days00Hrs00Min00SecExperimental image-based AI models are very good at extracting new information from standard H&E pathology slides. However\, the biological interpretation of these novel findings is a challenge. In this webinar\, Dr. Anna Laury\, Clinical Researcher at the University of Helsinki\, will explain how they used scanned H&E slides of high-grade serous carcinoma of the tube/ovary (HGSC) together with spatially resolved transcriptomics to explore whether AI findings actually represent biological differences in these tumors. \nHigh-grade serous carcinoma of the tube/ovary (HGSC) is characterized by aggressive behavior\, chemotherapy resistance\, and low 5-year survival\, but also exhibits striking variability in outcome. Our understanding of this disease is limited\, partly due to considerable tumor heterogeneity\, and predicting any individual patient’s response to therapy is challenging. \nDr. Laury’s team used Aiforia® Create to train an AI model to predict patient outcome in HGSC by identifying tumor regions that are highly associated with outcome status. The tumor regions identified by the AI model are currently indistinguishable by pathologists. They then used spatially resolved transcriptomics to profile these AI-identified tumor regions and identify molecular features related to disease outcome. \nRegister for the webinar to hear more about this proof-of-concept study\, which shows that AI-guided spatial transcriptomic analysis improves recognition of biologic features relevant to patient outcomes. \nRegister NowSpeakersAnna Laury\, MD\, PhD\nClinical Researcher\nUniversity of Helsinki \nDr. Laury is a clinical researcher at the University of Helsinki. She received her medical degree from the University of California\, Los Angeles and pathology training at Brigham & Women’s Hospital. Her clinical interests include women’s and perinatal pathology\, and her research is currently focused on the development and progression of tubo-ovarian serous carcinoma. \nDarshan Kumar\, PhD\nDirector of the Global FAS team\nAiforia Technologies \nDarshan Kumar has worked at Aiforia for over four years as a Customer Success Manager and Scientist. He currently leads the global team of Field Application Scientists. He did his PhD research in cell and molecular biology at the University of Helsinki and has a master’s in Biomedical Sciences from Leiden University.
URL:https://www.pathologynews.com/event/can-ai-predict-patient-outcomes-in-ovarian-cancer/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Can-AI-Predict-Patient-Outcomes-in-Ovarian-Cancer.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250715T100000
DTEND;TZID=UTC:20250715T110000
DTSTAMP:20260828T235951
CREATED:20250703T152203Z
LAST-MODIFIED:20250704T105216Z
UID:100114045-1752573600-1752577200@www.pathologynews.com
SUMMARY:EMEA Educational Xenium Webinar Series - Combine the power of single cell & spatial to make the impossible\, possible
DESCRIPTION:Part 1/3 – Panel DesignReveal new insights into cellular structure and function by enabling the mapping of 100s–5\,000s of RNA targets in fresh frozen and FFPE samples with true tissue context. Built on years of innovation in single cell and spatial technologies\, Xenium is a complete platform that streamlines going from tissue section to data\, with a state-of-the-art analyzer and a wide selection of curated panels and/or customization options. Xenium’s Onboard Analysis automatically processes data during a run allowing immediate interactive visualization with the powerful and intuitive Xenium Explorer. \nXenium offers best-in-class sensitivity\, specificity\, and highly confident transcript-to-cell assignments using multimodal cell segmentation. \nIn our three-part series\, each session will focus on an essential phase of a Xenium experiment\, guiding participants step by step through panel design\, workflow\, and data analysis. All sessions take place from July to October 2025. \nThe first webinar will focus on: \n\nOverview of technical concepts underlying Xenium\nThe design process using the Xenium Panel Designer (XPD)\nTips & tricks designing a new panel\n\nRegister NowSpeakerFallon Ratner\nApplied Bioinformatics Scientist\n10x Genomics
URL:https://www.pathologynews.com/event/emea-educational-xenium-webinar-series-combine-the-power-of-single-cell-spatial-to-make-the-impossible-possible/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/10x-Event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20250624T140000
DTEND;TZID=Europe/Paris:20250624T140000
DTSTAMP:20260828T235951
CREATED:20250616T133117Z
LAST-MODIFIED:20250616T133933Z
UID:100113578-1750773600-1750773600@www.pathologynews.com
SUMMARY:EMEA Educational Webinar - Deeper spatial discovery
DESCRIPTION:NEW! Visium HD 3’ assay\n10x Genomics is excited to introduce you to the newest member of the Visium HD family: the Visium HD 3’ assay\, which enables whole transcriptome spatial discovery with a 3’ poly(A) capture-based chemistry. See how the Visium HD 3′ assay makes the Visium platform a comprehensive spatial discovery solution\, compatible across any species or tissue condition and offering best-in-class data quality and join this upcoming webinar to see: \n\nComprehensive Workflow Overview: Follow the Visium HD 3’ assay from sample preparation through to data acquisition. Learn practical tips and best practices straight from the lab.\nHigh-Resolution Data Across Species: Explore stunning\, high-resolution spatial gene expression data from a variety of species\, including chicken\, zebrafish\, rat\, pig\, and more—see how Visium HD 3’ unlocks biological insights unlike any other approach.\nInteractive Technical Q&A: Bring your technical questions! Our experts will address challenges and discuss hands-on solutions for implementing Visium HD 3’ in your research.\n\nRegister NowSpeakersMonika Dabrowska \nField Application Scientist\n10x Genomics
URL:https://www.pathologynews.com/event/emea-educational-webinar-deeper-spatial-discovery/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/Deeper-spatial-discovery.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250619T160000
DTEND;TZID=Europe/London:20250619T170000
DTSTAMP:20260828T235951
CREATED:20250528T132919Z
LAST-MODIFIED:20250530T135341Z
UID:100113029-1750348800-1750352400@www.pathologynews.com
SUMMARY:Diagnexia Webinar Series - Introduction à la pathologie moléculaire (French)
DESCRIPTION:0000Days00Hrs00Min00SecJoin Diagnexia for a French-language webinar with Dr. Bettina Bisig\, offering an essential introduction to molecular pathology and its growing role in diagnosis and personalized medicine. \nThe French Webinar Series is an educational initiative designed specifically for French-speaking pathologists. Each session is conducted entirely in French and led by expert speakers covering essential topics in pathology\, with the aim of fostering learning\, professional development\, and knowledge exchange across the Francophone community. These free sessions offer a unique opportunity to learn from leading specialists\, participate in dynamic discussions\, and stay informed on key developments in the field. Webinars are open to pathologists across French-speaking countries and beyond. In our upcoming session\, we are pleased to welcome Dr. Bettina Bisig\, a recognized expert in molecular pathology with a strong background in diagnostic practice and pathology education. Her presentation will serve as an introduction to molecular pathology\, outlining fundamental principles\, clinical applications\, and the evolving role of molecular techniques in diagnosis and personalized medicine. Don’t miss this opportunity to explore the foundations of molecular pathology with one of the field’s most respected voices — en français. \nRegister Now
URL:https://www.pathologynews.com/event/diagnexia-webinar-series-introduction-a-la-pathologie-moleculaire-french/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Diagnexia-webinar-5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250611T180000
DTEND;TZID=Europe/London:20250611T180000
DTSTAMP:20260828T235951
CREATED:20250521T083916Z
LAST-MODIFIED:20250530T134915Z
UID:100112625-1749664800-1749664800@www.pathologynews.com
SUMMARY:Diagnexia Webinar Series -  Soft tissue and Bone (and other interesting cases)
DESCRIPTION:0000Days00Hrs00Min00SecJoin the Diagnexia Webinar Series \nStay informed with the latest insights and advancements in digital pathology\, led by experts from across the field. Explore key topics\, real-world applications\, and innovations shaping the future of diagnostics. \nJoin Dr. Kum Cooper for another engaging session of the Interactive Cooper Conference With Digital Slides\, where he will present and discuss fascinating soft tissue pathology cases. This highly interactive webinar will provide expert insights\, digital slide reviews\, and an opportunity for real-time learning. \nWhat to Expect:\n✅ High-impact case discussions in soft tissue pathology \n✅ Digital slides for interactive learning \n✅ Insights from one of the leading experts in pathology \nDon’t miss this opportunity to expand your diagnostic expertise! \nRegister Now
URL:https://www.pathologynews.com/event/diagnexia-webinar-series-soft-tissue-and-bone-and-other-interesting-cases/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Diagnexia-Webinar-3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250605T160000
DTEND;TZID=Europe/London:20250605T170000
DTSTAMP:20260828T235951
CREATED:20250523T103240Z
LAST-MODIFIED:20250530T134739Z
UID:100112863-1749139200-1749142800@www.pathologynews.com
SUMMARY:Diagnexia Webinar Series -  Diagnostico Citológico de Neoplasias Infrecuentes en Derrames. Un escenario Cada Vez mas Común
DESCRIPTION:0000Days00Hrs00Min00SecUpcoming LATAM Webinar – Don’t Miss Out! \nJoin Diagnexia for a free educational session with Prof. Jimenez Heffernan José on: Cytologic Diagnosis in Effusions: Classic and New Concepts \nLearn how to approach effusion cytology with confidence — from foundational criteria to new diagnostic concepts. \nLa serie de seminarios web LATAM es una iniciativa educativa diseñada especialmente para patólogos de habla hispana. Cada sesión se imparte completamente en español y está dirigida por expertos que abordan temas clave en anatomía patológica\, con el objetivo de fomentar el aprendizaje\, el crecimiento profesional y el intercambio de conocimientos en la comunidad. Estas sesiones gratuitas ofrecen una oportunidad única para aprender de especialistas líderes\, participar en discusiones enriquecedoras y mantenerse al día con los avances más recientes en la disciplina. Están abiertas a patólogos de toda América Latina y otras regiones interesadas. En nuestra próxima sesión contaremos con el Prof. Jimenez Heffernan José\, un destacado experto en citopatología con amplia experiencia clínica y docente. En esta charla\, abordará el diagnóstico citológico en derrames\, desde los principios clásicos hasta los conceptos emergentes. La presentación ofrecerá claves prácticas para la diferenciación entre procesos benignos y malignos\, el reconocimiento de artefactos diagnósticos y la aplicación de criterios actualizados en casos complejos. No se pierda esta oportunidad de aprendizaje con uno de los referentes en la materia. \nRegister Now
URL:https://www.pathologynews.com/event/diagnexia-webinar-series-diagnostico-citologico-de-neoplasias-infrecuentes-en-derrames-un-escenario-cada-vez-mas-comun/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/05/Diagnexia-Webinar-4.jpg
END:VEVENT
END:VCALENDAR